Primary Prevention of Cardiovascular Events in Diabetics – Use of Aspirin or Antiplatelet Therapy
-
The percentage of male diabetics, age 50 years or older, or female diabetics, aged 60 years or older, with a Framingham risk score > 10 who are taking aspirin or an antiplatelet agent.
CBE ID0632